tradingkey.logo

Mendra Launches With $82M Series A To Acquire, Develop, Commercialize Therapeutics For High Unmet Need Rare Diseases

ReutersJan 22, 2026 12:09 PM

-

  • MENDRA LAUNCHES WITH $82 MILLION SERIES A TO ACQUIRE, DEVELOP, AND COMMERCIALIZE THERAPEUTICS FOR HIGH UNMET NEED RARE DISEASES

  • MENDRA: ROUND WAS CO-LED BY ORBIMED, 8VC, AND 5AM VENTURES WITH PARTICIPATION FROM LUX CAPITAL AND WING VC

Further company coverage: [ ]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI